Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Venlafaxine Hydrochloride Sustained-Release Capsules

Approval Number

国药准字H20234024

Company湖北多瑞药业有限公司

Registration Date

August 8, 2023

Drug Information

Generic Name

盐酸文拉法辛缓释胶囊

Dosage Form

胶囊剂

Strength

150mg（按C₁₇H₂₇NO₂计）

Drug Type

化学药品

Registration Date

August 8, 2023

Company Information

Applicant Company

Company Name湖北多瑞药业有限公司

Company Address

湖北省荆州市公安县斗湖堤镇孱陵大道

Manufacturing Company

Company Name湖北多瑞药业有限公司

Company Address

湖北省荆州市公安县斗湖堤镇孱陵大道

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy